COPD and multimorbidity: recognising and addressing a syndemic occurrence
Open accessThe DOI matches its Crossref record; 164 of the 166 references it cites were found in a registry or an index.
Abstract
Most patients with chronic obstructive pulmonary disease (COPD) have at least one additional, clinically relevant chronic disease. Those with the most severe airflow obstruction will die from respiratory failure, but most patients with COPD die from non-respiratory disorders, particularly cardiovascular diseases and cancer. As many chronic diseases have shared risk factors (eg, ageing, smoking, pollution, inactivity, and poverty), we argue that a shift from the current paradigm in which COPD is considered as a single disease with comorbidities, to one in which COPD is considered as part of a multimorbid state-with co-occurring diseases potentially sharing pathobiological mechanisms-is needed to advance disease prevention, diagnosis, and management. The term syndemics is used to describe the co-occurrence of diseases with shared mechanisms and risk factors, a novel concept that we propose helps to explain the clustering of certain morbidities in patients diagnosed with COPD. A syndemics approach to understanding COPD could have important clinical implications, in which the complex disease presentations in these patients are addressed through proactive diagnosis, assessment of severity, and integrated management of the COPD multimorbid state, with a patient-centred rather than a single-disease approach.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“diseases are not evenly dispersed across populations but rather tend to cluster in disadvantaged groups that suffer elevated rates of multimorbidity”
From Is Pollution the Primary Driver of Infectious Syndemics? (2024) · cites this paper as [3]
In the citing paper
“such clustering increases opportunities for disease interactions across various biological and psychological pathways”
From Is Pollution the Primary Driver of Infectious Syndemics? (2024) · cites this paper as [3]
Citations
Cites
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Self-citationHallmarks of aging: An expanding universe
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2023) · Cell · doi:10.1016/j.cell.2022.11.001 · Cited by 6,549
Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925
Celli, B. R., MacNee, W., Agusti, A., Anzueto, A., Berg, B., Buist, A. S., Calverley, P. M. A., Chavannes, N., Dillard, T., Fahy, B., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,421
Self-citationCelli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
Self-citationInflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Ferrucci, L., & Fabbri, E. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0064-2 · Cited by 3,690
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
Solomon, S. D., McMurray, J. J. V., Claggett, B., de Boer, R. A., DeMets, D., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S. P., Martinez, F., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2206286 · Cited by 2,884
Empagliflozin in Patients with Chronic Kidney Disease
The EMPA-KIDNEY Collaborative Group (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2204233 · Cited by 2,754
Pulmonary rehabilitation for chronic obstructive pulmonary disease
McCarthy, B., Casey, D., Devane, D., Murphy, K., Murphy, E., & Lacasse, Y. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003793.pub3 · Cited by 2,643
Research works printed but not linked: 1
- 1987, This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986, Am Rev Respir Dis, 136, 225
Cited by
The global burden of COPD: epidemiology and effect of prevention strategies
de Oca, M. M., Perez-Padilla, R., Celli, B., Aaron, S. D., Wehrmeister, F. C., Amaral, A. F. S., Mannino, D., Zheng, J., Salvi, S., Obaseki, D., et al. (2025) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(24)00339-4 · Cited by 171
Self-citationPulmonary hypertension associated with lung diseases
Shlobin, O. A., Adir, Y., Barberà, J. A., Cottin, V., Harari, S. A., Jutant, E., Pepke‐Żaba, J., Ghofrani, H. A., & Channick, R. N. (2024) · European Respiratory Journal · doi:10.1183/13993003.01200-2024 · Cited by 179
“Furthermore, COPD is frequently associated with other diseases that also cause PH, in particular left heart disease [11].”
Lung-function trajectories: relevance and implementation in clinical practice
Melén, E., Faner, R., Allinson, J. P., Bui, D., Bush, A., Čustović, A., García‐Aymerich, J., Guerra, S., Breyer‐Kohansal, R., Hallberg, J., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00016-3 · Cited by 164
Self-citationEffects of population aging on quality of life and disease burden: a population-based study
Xi, J., Liang, B., Zhang, W., Yan, B., Dong, H., Chen, Y. Y., Lin, X., Gu, J., & Hao, Y. (2025) · Global Health Research and Policy · doi:10.1186/s41256-024-00393-8 · Cited by 117
“Multimorbidity usually involves different combinations of risk factors or pathobiological mechanisms, which may alter the benefits and effectiveness of health interventions [43, 44].”
Implications of Cardiopulmonary Risk for the Management of COPD: A Narrative Review
Singh, D., Han, M. K., Hawkins, N. M., Hurst, J. R., Kocks, J. W. H., SKOLNIK, N., Stolz, D., Khoury, J. E., & Gale, C. P. (2024) · Advances in Therapy · doi:10.1007/s12325-024-02855-4 · Cited by 87
“This indicates a syndemic occurrence, where shared risk factors, fundamental patho-biological and pathophysiological interactions and social determinants of health cause an aggregation of the two diseases and exacerbate the burden and prognosis of disease [11].”
BackgroundSelf-citation
Metadata
- Authors
- Fabbri, L. M., Celli, B. R., Agustí, A., Criner, G. J., Dransfield, M. T., Divo, M., Krishnan, J. K., Lahousse, L., Montes de Oca, M., Salvi, S. S., Stolz, D., Vanfleteren, L. E. G. W., & Vogelmeier, C. F.
- Affiliations
- University of Ferrara (IT)
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
- Temple University (US)
- University of Alabama at Birmingham (US)
- Brigham and Women's Hospital (US)
- Weill Cornell Medicine (US)
- Ghent University (BE)
- Symbiosis International University (IN)
- University of Freiburg (DE)
- Sahlgrenska University Hospital (SE)
- Philipps University of Marburg (DE)
- Corresponding author
- Vogelmeier, Claus F
- ORCID
- Venue
- The Lancet Respiratory Medicine
- Publisher
- Elsevier BV
- Published
- 2023-11
- Volume
- 11
- Issue
- 11
- Pages
- 1020-1034
- ISSN
- 2213-2600 (ISSN-L)
- OpenAlex
- W4386532354
- Semantic Scholar
- 6d51d5c8bea6867f3623fd24d197b2304d2dd09c
- Cited by
- 274
- References
- 166
- Citations by year
- 2026: 97 · 2025: 110 · 2024: 65 · 2023: 2
- FWCI
- 12.68
- Type
- journal article
- Language
- en
- Open access
- green
- biblio.ugent.be
- Licence
- other-oa
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- The Lancet Respiratory Medicine (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, other-oa)
- Funders
- Università degli Studi di Ferrara
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- chronic obstructive pulmonary disease, multimorbidity, syndemic, comorbidities, cardiovascular disease, cancer, shared risk factors, disease severity assessment, integrated disease management, patient-centered care, disease prevention
- MeSH terms
- Multimorbidity, Syndemic, Humans, Lung, Comorbidity, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: COPD and multimorbidity: recognising and addressing a syndemic occurrence. https://app.cochat.ai/papers/10.1016/s2213-2600(23)00261-8
- The paper
- Fabbri, L. M., Celli, B. R., Agustí, A., Criner, G. J., Dransfield, M. T., Divo, M., Krishnan, J. K., Lahousse, L., Montes de Oca, M., Salvi, S. S., Stolz, D., Vanfleteren, L. E. G. W., & Vogelmeier, C. F. (2023). COPD and multimorbidity: recognising and addressing a syndemic occurrence. The Lancet Respiratory Medicine. https://doi.org/10.1016/s2213-2600(23)00261-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.